1. Home
  2. MHK vs MIRM Comparison

MHK vs MIRM Comparison

Compare MHK & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mohawk Industries Inc.

MHK

Mohawk Industries Inc.

HOLD

Current Price

$107.52

Market Cap

6.2B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$119.90

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHK
MIRM
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
7.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
MHK
MIRM
Price
$107.52
$119.90
Analyst Decision
Buy
Strong Buy
Analyst Count
11
13
Target Price
$126.10
$119.85
AVG Volume (30 Days)
735.1K
967.0K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
74.59
EPS
1.90
N/A
Revenue
N/A
$19,138,000.00
Revenue This Year
$3.38
$26.22
Revenue Next Year
$3.09
$22.04
P/E Ratio
$57.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$92.99
$50.25
52 Week High
$143.13
$130.00

Technical Indicators

Market Signals
Indicator
MHK
MIRM
Relative Strength Index (RSI) 44.37 57.27
Support Level $104.49 $88.92
Resistance Level $107.98 N/A
Average True Range (ATR) 4.39 6.48
MACD -1.45 0.07
Stochastic Oscillator 8.20 59.29

Price Performance

Historical Comparison
MHK
MIRM

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: